A study of TAR-200 in combination with cetrelimab versus concurrent chemoradiotherapy in participants with muscle-invasive bladder cancer (MIBC) of the Bladder

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2021
This article has no abstract
Epistemonikos ID: 38af5808bcdfc9f50d4cf0629e4ce87fb7b28e90
First added on: Apr 11, 2025